Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
As an expert shopper, I've cracked the code for no-fuss holiday shopping: beauty gift sets. They offer the most bang for your buck with multiple beauty products all wrapped up in one dainty ...